| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/03/2009 | US20090220572 Injectable Combination Therapy for Eye Disorders |
| 09/03/2009 | US20090220570 Axon Regeneration with PKC Inhibitors |
| 09/03/2009 | US20090220562 Osteogenic and anti-adipogenic oxysterols |
| 09/03/2009 | US20090220554 Transglutaminase Inhibitors and Methods of Use Thereof |
| 09/03/2009 | US20090220551 Concurrent chemotherapy and immunotherapy |
| 09/03/2009 | US20090220533 Novel T-Helper Antigenic Determinant (THD) Peptides |
| 09/03/2009 | US20090220531 Composition of which Chief Ingredient is Polysaccharides Having an Immunoregulatory Function |
| 09/03/2009 | US20090220518 Methods and compositions for treatment of graft rejection and promotion of graft survival |
| 09/03/2009 | US20090220516 Neuroprotection of retinal ganglion cells |
| 09/03/2009 | US20090220513 Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications |
| 09/03/2009 | US20090220512 Genes and polypeptides relating to prostate cancers |
| 09/03/2009 | US20090220511 human polypeptides named IFN (interferon)- lambda 1, IFN- lambda 2 and IFN- lambda 3 and IFN- lambda R1; antiviral agents |
| 09/03/2009 | US20090220509 Singlec-9 binding agents |
| 09/03/2009 | US20090220505 Methods of inhibiting amyloid toxicity |
| 09/03/2009 | US20090220502 B7 FAMILY MEMBER zB7H6 AND RELATED COMPOSITIONS AND METHODS |
| 09/03/2009 | US20090220495 Cancer Related Genes (PRLR) |
| 09/03/2009 | US20090220492 Protein purification |
| 09/03/2009 | US20090220491 Binding agents which inhibit myostatin |
| 09/03/2009 | US20090220490 Compositions and Assays for Inhibiting HCV Infection |
| 09/03/2009 | US20090220488 Evaluating and treating scleroderma |
| 09/03/2009 | US20090220487 via blocking proteins and signal transduction pathways, with peptide which inhibits p21-activated kinase (PAK)-PIX-GIT interaction or complex formation; mitogen-activated protein kinase inhibitors; tissue damage, ischemia, inflammation, stroke, wound healing, acute respiratory distress syndrome |
| 09/03/2009 | US20090220483 Stable Enzymatic Preparations and Methods of Use Thereof |
| 09/03/2009 | US20090220482 Methods and compositions for delivering interleukin-1 receptor antagonist |
| 09/03/2009 | US20090220481 Method and compositions for treating skin |
| 09/03/2009 | US20090220480 Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them |
| 09/03/2009 | US20090220479 Egln2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart disease |
| 09/03/2009 | US20090220478 Pharmaceutical active substance |
| 09/03/2009 | US20090220476 Laglidadg homing endonuclease variants having mutations in two functional subdomains and use thereof |
| 09/03/2009 | US20090220473 Adir related polymorphisms and applications thereof |
| 09/03/2009 | US20090220470 Ubiquitin binding polypeptides |
| 09/03/2009 | US20090220469 Peptides against autoantibodies associated with glaucoma and use of these peptides |
| 09/03/2009 | US20090220465 Methods and compositions for modulation of stem cell aging |
| 09/03/2009 | US20090220463 Pharmaceutical Composition For Treating Vascular-Related Diseases Comprising Peptide |
| 09/03/2009 | US20090220460 Virus strains |
| 09/03/2009 | US20090220457 Combinations comprising hcv protease inhibitor(s) and hcv ires inhibitor(s), and methods of treatment related thereto |
| 09/03/2009 | US20090220456 Uses of interferons with altered spatial structure |
| 09/03/2009 | US20090220455 Pharmaceutical compositions comprising elp fusion proteins |
| 09/03/2009 | US20090220454 Use of the histone deacetylase inhibitor N-hydroxy-4-[2-(3-dimethylaminobenzofuran-2-ylcarbonylamino)ethoxy]benzamide (aka CRA-24781, PCI-24781) for treating myelogenous leukemia (MML) or acute myelogenous leukemia (AML), optionally in combination therapy |
| 09/03/2009 | US20090220453 Enhancing stem cell mobilization |
| 09/03/2009 | US20090220452 Method Of Producing A Modified (POLY) Peptide |
| 09/03/2009 | US20090220451 Cyclopropyl compounds and compositions for delivering active agents |
| 09/03/2009 | US20090220450 Methods and compositions for wound healing |
| 09/03/2009 | US20090220435 Tight junction modulating peptide components for enhancing mucosal delivery of therapeutic agents |
| 09/03/2009 | US20090220432 Imaging agents and methods of using same for detecting multidrug resistance in cancer |
| 09/03/2009 | US20090220422 Drug Delivery Material |
| 09/03/2009 | DE19521720B4 Insulinanalogonformulierungen Insulin analog formulations |
| 09/03/2009 | DE102008011868A1 Combined agent, useful e.g. to treat bone diseases, which are conditioned by increased osteoclastic activity, and osteoporosis, comprises two separate agents such as carboanhydrase-inhibitor and/or H(+)-ATPase inhibitor and parathormone |
| 09/03/2009 | DE102004028899B4 Verwendung einer Kombination zur präventiven und/oder therapeutischen Behandlung von bakteriell bedingten Infektionserkrankungen oder der Sepsis Using a combination of preventive and / or therapeutic treatment of bacterial infectious diseases or sepsis |
| 09/03/2009 | CA2717193A1 Method for achieving desired glial growth factor 2 plasma levels |
| 09/03/2009 | CA2716893A1 Use of s-adenosylmethionine (sam) and superoxide dismutase (sod) for the preparation of medicaments for the treatment of alzheimer's disease |
| 09/03/2009 | CA2716852A1 High-molecular-weight adiponectin measurement method |
| 09/03/2009 | CA2716780A1 Prophylactic or therapeutic agent for diabetes or obesity |
| 09/03/2009 | CA2716650A1 Cosmetic or pharmaceutical compositions comprising metalloproteinase inhibitors |
| 09/03/2009 | CA2716622A1 Glycopeptides and methods of making and using them |
| 09/03/2009 | CA2716615A1 An engineered cxcl12 alpha locked dimer polypeptide |
| 09/03/2009 | CA2716565A1 Pharmaceutical composition for transnasal administration |
| 09/03/2009 | CA2716400A1 Method for increasing the activity of the immune system of a mammal at risk of inflammatory diseases |
| 09/03/2009 | CA2713095A1 Biological materials and uses thereof |
| 09/03/2009 | CA2711866A1 Use of a homeoprotein of the bicoid family for preventing or treating retinal ganglionic neurone degeneration |
| 09/02/2009 | EP2096167A1 Aptamer against midkine and use thereof |
| 09/02/2009 | EP2096120A2 Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| 09/02/2009 | EP2096118A1 Antifungal peptides |
| 09/02/2009 | EP2095828A1 Use of S-adenosylmethionine (SAM) and superoxide dismutase (SOD) for the preparation of medicaments for the treatment of Alzeimer's disease |
| 09/02/2009 | EP2095827A1 High affinity human monoclonal antibodies specific for RSV F-protein |
| 09/02/2009 | EP2095825A1 Method for treating human diseases associated with an increased deoxyribonucleic acid content in extracellular spaces of tissues and a medicinal preparation for carrying out said method |
| 09/02/2009 | EP2095824A1 A method for restoring BMP-receptor signaling in a cell |
| 09/02/2009 | EP2095823A1 GM-CSF for treating demyelination |
| 09/02/2009 | EP2095822A1 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides |
| 09/02/2009 | EP2095821A1 Anticancer agent |
| 09/02/2009 | EP2095820A1 Fermented milk for improving and/or treating skin and method for producing the same |
| 09/02/2009 | EP2095127A1 Methods for screening and treatment involving the genes gypc, agpat3, agl, pvrl2, hmgb 3, hsdl2 and/or ldb2 |
| 09/02/2009 | EP2094832A1 Methods and compositions for reducing amyloid beta levels |
| 09/02/2009 | EP2094720A1 Selective inhibitors of neurotensin degrading enzymes |
| 09/02/2009 | EP2094309A2 Alpha-lactalbumin composition |
| 09/02/2009 | EP2094305A2 Method for treating pathological pulmonary conditions and bleomycin associated pulmonary fibrosis |
| 09/02/2009 | EP2094301A1 Poxviridae treatment comprising tap-1 and/or tap-2 as a molecular adjuvant |
| 09/02/2009 | EP2094299A1 Recombinant modified vaccinia virus ankara (mva)-based vaccine for the avian flu |
| 09/02/2009 | EP2094292A2 Nitric oxide-blocked cross-linked tetrameric hemoglobin |
| 09/02/2009 | EP2094291A1 Dimeric prolactin receptor ligands |
| 09/02/2009 | EP2094290A2 Enhancing pulmonary host defense via administration of granulocyte-macrophage colony stimulating factor |
| 09/02/2009 | EP2094289A1 Conjoint therapy for treating fibrotic diseases |
| 09/02/2009 | EP2094288A2 Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage |
| 09/02/2009 | EP2094283A1 Method for in situ solidification of blood-polymer compositions for regenerative medicine and cartilage repair applications |
| 09/02/2009 | EP2094274A2 T-140 peptide analogs having cxcr4 super-agonist activity for bone marrow recovery |
| 09/02/2009 | EP2094237A1 Lipid growth factor formulations |
| 09/02/2009 | EP2094201A2 Designed degradable cage coated with mineral layers for spinal interbody fusion |
| 09/02/2009 | EP2094170A2 Device for removing blood clots from blood vessels |
| 09/02/2009 | EP1957098B1 Management of non septic patients suffering from partial thickness burns by administration of activated protein c |
| 09/02/2009 | EP1951282A4 Treatment of hypersensitivity |
| 09/02/2009 | EP1868629A4 Therapeutic peptides for the treatment of metastatic cancer |
| 09/02/2009 | EP1812032A4 Tissue factor composition and methods |
| 09/02/2009 | EP1761274B1 Factor viia or factor viia equivalents for preventing or attentuating haemorrhage growth, and/or oedema generation following intracerebral haemorrhage (ich) |
| 09/02/2009 | EP1753448A4 Compositions comprising various proteorhodopsins and/or bacteriorhodopsins and use thereof |
| 09/02/2009 | EP1620056B1 Tumor cytotoxicity induced by modulators of the cxcr4 receptor |
| 09/02/2009 | EP1585817B1 Conjugates comprising a biodegradable polymer and uses therefor |
| 09/02/2009 | EP1558278B1 Production of homotrimeric fusion proteins |
| 09/02/2009 | EP1557466B1 Tumor antigen protein and utilization thereof |
| 09/02/2009 | EP1523372B1 Ghrelin-carrier conjugates |
| 09/02/2009 | EP1495045B1 Cytoplasmic transduction peptides and uses thereof |
| 09/02/2009 | EP1481056B1 Modified human manganese superoxide dismutase and uses therof |